MedDataX Logo

Time To Efficacy and Onset Of Action Of Linezolid

NCT ID: NCT00147511

Last Updated: 2011-05-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

118 participants

Study Classification

INTERVENTIONAL

Study Start Date

2003-06-30

Study Completion Date

2005-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To assess the onset of action of linezolid

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

A Study To Assess The Effect Of Linezolid On QTc Interval

NCT00795145

Bacterial Infections
COMPLETED PHASE1

A Pediatric Taste Test Study of Omnicef Versus Zithromax Antibiotic Suspension Medications

NCT00644774

Healthy
COMPLETED PHASE4

Cefixime / Azithromycin pK Study

NCT02708992

Gonorrhoea
COMPLETED PHASE1

Study of Nitazoxanide (NTZ) for Helicobacter Pylori in Children

NCT04415983

Helicobacter Pylori Infection
RECRUITING PHASE3

Special Investigation Of Azithromycin IV For Legionnaires' Disease (Regulatory Post Marketing Commitment Plan)

NCT01784770

Legionnaires' Disease Legionella Pneumophila Infections
COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gram-Positive Bacterial Infections Skin and Connective Tissue Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

linezolid

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* suspected grampositive infection
* fever \> 38 C

Exclusion Criteria

* Infections to be treated successfully by surgical procedures
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Pfizer

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Pfizer

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Pfizer CT.gov Call Center

Role: STUDY_DIRECTOR

Pfizer

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

OXAA-0026-162

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Population Pharmacokinetics of Meropenem and Linezolid in Children With Severe Infectious Diseases
NCT03643497 UNKNOWN
Zithromax-SR 2g, Special Investigation (Regulatory Post Marketing Commitment Plan)
NCT00998309 COMPLETED
A Single Center Four Part Study in Healthy Adult Subjects to Evaluate: the Safety, Tolerability and Pharmacokinetics of a Single Oral Dose and Repeat Escalating Oral Doses of GSK945237; the Effect of Linezolid on Hematology Safety Parameters; and the Effects of GSK945237 and Moxifloxacin on QTc.
NCT01039610 WITHDRAWN PHASE1
Efficacy and Safety of 14-day Concomitant Therapy for Refractory Helicobacter Pylori Infection
NCT05133193 UNKNOWN NA
Safety and Efficacy Study to Compare Two Rosacea Treatment Regimens
NCT00495313 COMPLETED PHASE4
Early Bactericidal Activity of Linezolid, Gatifloxacin, Levofloxacin, Isoniazid (INH) and Moxifloxacin in HIV Negative Adults With Initial Episodes of Sputum Smear-Positive Pulmonary Tuberculosis
NCT00396084 COMPLETED PHASE1/PHASE2
Evaluation of Bacteria in the Mouth and Throat of Healthy Adults Before and After the Administration of Either Levofloxacin or Azithromycin, Both Antibiotic Medications
NCT00821782 COMPLETED PHASE1
Nitazoxanide and Lansoprazole Based Regimens for H. Pylori Management
NCT05184491 UNKNOWN PHASE4
Comparative Study of Levonadifloxacin (IV and Oral) With Linezolid (IV and Oral) in Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
NCT03405064 COMPLETED PHASE3
Trial to Evaluate Nitazoxanide for Treatment of Mild or Moderate COVID-19 in Subjects at High Risk of Severe Illness
NCT05157243 WITHDRAWN PHASE3
PK of Levofloxacin in MDR-TB Patients
NCT03000517 COMPLETED
Intravenous Azithromycin Plus Intravenous Ceftriaxone Followed by Oral Azithromycin With Intravenous Levofloxacin Followed by Oral Levofloxacin for the Treatment of Moderate to Severely Ill Hospitalized Patients With Community Acquired Pneumonia
NCT00035347 COMPLETED PHASE4
Safety, Tolerability, and Pharmacokinetics of Multiple Doses of Intravenous Nafithromycin
NCT03981887 COMPLETED PHASE1
Study Comparing the Clinical Efficacy and Health Outcomes of Outpatients With Mild to Moderate Community-Acquired Pneumonia (CAP) Treated With Either Telithromycin Once Daily for 7 Days, or Azithromycin Once Daily for 5 Days
NCT00237445 TERMINATED PHASE4
A Comparison of Safety and Efficacy of Cefdinir Oral Suspension Versus Azithromycin in Pediatric Subjects With Acute Otitis Media
NCT00645112 COMPLETED PHASE4
Delafloxacin Versus Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections
NCT01811732 COMPLETED PHASE3
Skin Inflammation and PK of Azithromycin
NCT06170983 NOT_YET_RECRUITING NA
Comparative Effectiveness of Antibiotics for Respiratory Infections
NCT02297815 COMPLETED
Zoliflodacin in Uncomplicated Gonorrhoea
NCT03959527 COMPLETED PHASE3
Evaluate Pathogens and Immunity to Acute Otitis Media in Healthy Children.
NCT02591563 ACTIVE_NOT_RECRUITING
Comparison of the Pharmacodynamics of Imipenem in Patients With Febrile Neutropenia
NCT02213783 COMPLETED PHASE4
Comparative Study to Evaluate the Efficacy and Safety of Telithromycin Given Once Daily Versus Cefuroxime Axetil Given Twice Daily in Children With Middle Ear Infections
NCT00174811 TERMINATED PHASE3
Safety and Tolerability of Ceftazidime-Avibactam for Pediatric Patients With Suspected or Confirmed Infections
NCT01893346 COMPLETED PHASE1
KEYS: Study Comparing Clinical Health Outcomes of Telithromycin Versus Azithromycin in Outpatients With Community-acquired Lower Respiratory Tract Infections
NCT00132951 TERMINATED PHASE4
Compliance And Safety Study In Children With Upper And Lower Respiratory Tract Infections
NCT00939185 COMPLETED